Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare

TAIPEI, Taiwan, Feb. 11, 2019 /PRNewswire/ -- An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program ... Lees verder

Bron:

ANP Pers support